Comparative Pharmacology
Head-to-head clinical analysis: DIANEAL PD 2 W DEXTROSE 3 5 IN PLASTIC CONTAINER versus INPERSOL ZM W DEXTROSE 1 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIANEAL PD 2 W DEXTROSE 3 5 IN PLASTIC CONTAINER versus INPERSOL ZM W DEXTROSE 1 5 IN PLASTIC CONTAINER.
DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER vs INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dianeal PD-2 with Dextrose 3.5% is a peritoneal dialysis solution. Dextrose provides an osmotic gradient that facilitates the removal of uremic toxins and excess fluid from the blood across the peritoneal membrane into the dialysate. The solution also contains electrolytes to correct imbalances.
Inpersol-ZM w/ Dextrose 1.5% is a peritoneal dialysis solution that acts by creating a concentration gradient across the peritoneal membrane. The dextrose component provides an osmotic driving force that promotes ultrafiltration and removal of waste products (e.g., urea, creatinine) and excess electrolytes from the blood into the dialysate fluid, which is then drained from the peritoneal cavity. The electrolyte composition (sodium, chloride, calcium, magnesium, lactate) helps correct acid-base and electrolyte imbalances.
2 to 3 liters intraperitoneally, 4 exchanges daily, with dwell times of 4-6 hours for CAPD; or 2 to 2.5 liters intraperitoneally, cycler-assisted, 3-5 cycles nightly for APD. Dextrose 3.5% solution used based on ultrafiltration needs.
250 mL to 2 L intraperitoneally, instilled over 10-20 minutes, dwell for 4-6 hours, then drain. Typically 4 exchanges per day.
None Documented
None Documented
The elimination half-life of dextrose from the systemic circulation is approximately 3.5-4.5 hours after intraperitoneal administration. Clinically, this reflects the rate of glucose absorption and metabolism, which can be altered in patients with impaired glucose tolerance or diabetes.
Not applicable systemically; dextrose half-life is minutes due to rapid cellular uptake. In peritoneal dialysis, the half-life of glucose in the peritoneal cavity is approximately 30-60 minutes due to absorption into bloodstream.
Peritoneal dialysis (PD) with 3.5% dextrose solution results in elimination of excess fluid and solutes via the peritoneal membrane. Dextrose is absorbed systemically and metabolized. The primary route of elimination of dialytic waste products (e.g., urea, creatinine) is via the peritoneal fluid itself, which is drained. Less than 1% of dextrose is excreted unchanged in urine. Biliary/fecal excretion is negligible.
Renal: 100% (dialysis fluid containing dextrose is removed directly; glucose is metabolized and not excreted unchanged). Dextrose undergoes cellular metabolism to CO2 and water.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution